Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) - protocol presentation

被引：0
|
作者：
Mozga, Maria [1 ]
Malysiak-Szponder, Sylwia [2 ]
Milkowska-Dymanowska, Joanna [1 ]
Bialas, Adam J. [1 ]
Piotrowski, Wojciech J. [1 ]
机构：
[1] Med Univ Lodz, Lodz, Poland
[2] Roche Poland, Lodz, Poland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Idiopathic pulmonary fibrosis; Personalised medicine; Telemedicine;
D O I：
10.1183/13993003.congress-2020.1812
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1812
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
    Gagiannis, Daniel
    Steinestel, Julie
    Hackenbroch, Carsten
    Schreiner, Benno
    Hannemann, Michael
    Bloch, Wilhelm
    Umathum, Vincent G.
    Gebauer, Niklas
    Rother, Conn
    Stahl, Marcel
    Witte, Hanno M.
    Steinestel, Konrad
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [42] Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
    Boutel, Maria
    Boutou, Afroditi
    Pitsiou, Georgia
    Garyfallos, Alexandros
    Dimitroulas, Theodoros
    DIAGNOSTICS, 2023, 13 (07)
  • [43] Remote Early Identification of Disease Progression in Connective Tissue Disease related Interstitial Lung Disease (CTD-ILD) using Digital Patient Empowered Monitoring
    Ng, W. L.
    O'Farrell, R.
    Schweikert, A.
    Howard, D.
    Durcan, L.
    Hurley, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [44] EFFICACY OF RITUXIMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASES - A RETROSPECTIVE ANALYSIS
    Jethwa, H.
    Patel, I.
    Steuer, A.
    Demetriadi, F.
    Power, S.
    Adler, M.
    Lloyd, M.
    Pretsell, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 751 - 751
  • [45] Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects
    Malysiak-Szpond, Sylwia
    Mozga, Maria
    Miadlikowska, Ewa
    Milkowska-Dymanowska, Joanna
    Bialas, Adam Jerzy
    Piotrowski, Wojciech Jerzy
    PLOS ONE, 2022, 17 (12):
  • [46] DEVELOPING A DISEASE ACTIVITY AND THERAPEUTIC RESPONSE INDEX IN CONNECTIVE TISSUE DISEASE - INTERSTITIAL LUNG DISEASE (CTD-ILD): RESULTS FROM A DELPHI EXERCISE: CONSENSUS ON DOMAINS
    Saketkoo, L. A.
    Khanna, D.
    Huscher, D.
    Dellaripa, P.
    Flaherty, K.
    Matteson, E.
    Oddis, C.
    Wells, A.
    Denton, C.
    Distler, O.
    Kowal-Bielecka, O.
    Sandorfi, N.
    Christmann, R.
    Phillips, K.
    Pittrow, D.
    Strand, V.
    Brown, K.
    Seibold, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 52 - 52
  • [47] Connective Tissue Disease-Associated Interstitial Lung Diseases: Unresolved Issues
    Jarana Aparicio, Irene
    Lee, Joyce S.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (03) : 468 - 476
  • [48] PATTERN OF AUTOANTIBODIES INVOLVEMENT IN CONNECTIVE TISSUE DISORDER ASSOCIATED INTERSTITIAL LUNG DISEASES
    Jayasinghe, Prasanjanie Anuruddhika
    Krishnakumar, Prathapan
    Fernando, Amitha
    RESPIROLOGY, 2019, 24 : 242 - 243
  • [49] Characteristics of patients with connective tissue disease-associated interstitial lung diseases
    Aboud, Fatma M.
    Behiry, Mervat E.
    Ibraheem, Tamer M. A.
    Salama, Asmaa M. M.
    Abdalgaleel, Shaimaa A.
    Abd EL-Khalik, Dina M.
    EGYPTIAN RHEUMATOLOGIST, 2025, 47 (01): : 6 - 11
  • [50] PROGRESSIVE PULMONARY FIBROSIS IN CONNECTIVE TISSUE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASES
    Chiu, Y. H.
    Koops, M.
    Voortman, M.
    Van Es, H. W.
    Langezaal, L.
    Welsing, P.
    Jamnitski, A.
    Wind, A.
    Van Laar, J. M.
    Grutters, J. C.
    Spierings, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 789 - 790
12345